sunitinib alone

DRUG2 trials

Sponsors

Indiana University, Assistance Publique - Hôpitaux de Paris

Conditions

Breast CancerMetastatic Renal Cell Carcinoma

Phase 3

Clinical Trial to Assess the Importance of Nephrectomy

CompletedNCT00930033

Assistance Publique - Hôpitaux de ParisMetastatic Renal Cell Carcinoma

Start: 2009-09-09End: 2018-10-22Updated: 2025-09-05

Unknown Phase

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

CompletedNCT00656669

Indiana UniversityBreast Cancer

Start: 2008-04-30End: 2010-09-30Updated: 2023-05-23

Related Papers

Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma

CA A Cancer Journal for Clinicians2024-04-033 citations

Cytoreductive nephrectomy (CN) in metastatic renal cancer (mRCC): Update on Carmena trial with focus on intermediate IMDC-risk population.

Journal of Clinical Oncology2019-05-2061 citations

CARMENA: Cytoreductive nephrectomy followed by sunitinib versus sunitinib alone in metastatic renal cell carcinoma—Results of a phase III noninferiority trial.

Journal of Clinical Oncology2018-06-0715 citations

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

New England Journal of Medicine2018-06-03909 citations